Overview

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Status:
Completed

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

This study evaluates long-term safety in patients with macular edema due to Retinal Vein Occlusion (RVO) originally enrolled in the BRAVO & CRUISE trials and subsequently followed in the HORIZON extension trial.

Phase:

Phase 3

Details

Lead Sponsor:

Peter A Campochiaro, MD

Collaborators:

Genentech, Inc.
The Macula Foundation, Inc.

Treatments:

Ranibizumab